Back

Correction to: Anthracycline-induced cardiovascular toxicity: validation of the Heart Failure Association and International Cardio-Oncology Society risk score

European Heart Journal

18 November 2024
Organised by: Logo
Read full article
ESC Journals
You may be interested in
thumbnail
Congress Presentation
Cardiac dysfunction related to cancer therapy: can we predict who will develop it?
29 August 2022
thumbnail
Congress Presentation
Three-year follow-up of anthracycline-induced cardiotoxicity risk in breast cancer patients using the HFA-ICOS score
21 June 2025
thumbnail
Congress Session
Recent perspectives in cardio-oncology
17 May 2025
thumbnail
ESC Journals
Uprising heart failure therapies for cardio-permissive strategies in cancer therapy-related cardiac dysfunction
1 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources